The China Securities Regulatory Commission has informally raised the bar for humanoid robotics startups seeking to list on mainland exchanges, issuing "window guidance" to investment banks and firms after Unitree shares retraced nearly 60% from their post-debut highs3,5,11.
The guidance, first reported by the Information on September 9, requires humanoid IPO candidates to demonstrate recurring revenue, show a credible path to narrowing losses, or prove genuine technological innovation before applications will be considered13. Startups that copy existing models are barred from consideration8. The Wall Street Journal separately reported that regulators have signaled humanoid companies seeking to list should demonstrate stronger financials, revenue potential, and proprietary breakthroughs14.
Unitree's post-debut collapse
Unitree, China's best-known humanoid robot maker, debuted on the Shanghai Stock Exchange's STAR Market on August 19, 2026, closing its first session at 845 yuan per share, a 460% surge from its IPO price of 150.80 yuan6,9. The stock briefly touched 1,100 yuan intraday, pushing the company's valuation to roughly 445 billion yuan (approximately $66 billion). By Wednesday's close, shares had fallen to 513.93 yuan ($72.10), down about 53% from that peak and roughly 39% below the debut close7. The decline wiped out roughly 237 billion yuan in market capitalization from the high.
Unitree raised about 6.1 billion yuan ($900 million) through the IPO after initially targeting a valuation of roughly 42 billion yuan ($6.2 billion). At Wednesday's close, the company was valued at approximately $30 billion, equivalent to around 125 times its 2025 revenue and more than 350 times its adjusted 2025 earnings.
Revenue versus valuation
Unitree generated 1.70 billion yuan ($252 million) in revenue in 2025, up from 392.77 million yuan in 2024. Revenue from humanoid robots reached 868 million yuan in 2025, accounting for 51.78% of total revenue, and the company shipped more than 5,500 humanoids during the year. Net profit swung from a loss of 18.02 million yuan in 2023 to a profit of 590.75 million yuan in 2025. Unitree projected first-half 2026 revenue of between 1.052 billion and 1.128 billion yuan, representing year-on-year growth of roughly 36% to 45%.
In the first nine months of 2025, research and education accounted for 73.6% of Unitree's humanoid-robot revenue, commercial and consumer sales for 17.39%, and industrial applications for 9.01%. More than 40% of total 2025 revenue came from overseas.
Wider pipeline at risk
The regulatory shift is expected to affect Deep Robotics and Leju Robot, both of which remain unprofitable after filing for IPOs4. Rival Robotera is weighing a separate Hong Kong IPO12. Robotics concept stocks in Hong Kong extended their decline amid the reports.
The tighter stance was prompted by a funding frenzy in the private market in 2026, a long list of companies that have filed for IPOs, and the tanking share prices of recently listed firms. Regulators did not respond to a Reuters request for comment, and Reuters could not independently verify the Information's report.
Vector Wire covered the initial regulatory signal on September 10. The updated reporting from the South China Morning Post on September 15 adds detail on the specific financial and innovation criteria regulators plan to enforce and names the companies most likely to be affected. Nomura initiated coverage of Unitree in August with a buy rating and a target price of 370 yuan, based on a 25-times forecast 2027 price-to-sales multiple, well below the current trading level.
ANALYSIS The CSRC's intervention targets a valuation disconnect: Unitree trades at roughly 125 times revenue despite being profitable, while peers seeking to list have yet to turn a profit. The guidance effectively filters the IPO queue by commercial viability rather than sector enthusiasm.